Unit A · Plot A · Genome Valley Phase III

~25,000 sq ft
Manufacturing Unit

Remaining buildable capacity on the existing one-acre site. Available shell-and-core for tenants who self-fit to their own GMP standard, or delivered as a fully fitted, cleanroom-ready, manufacturing-ready facility.

Available to Lease Shell-and-core Turnkey Available Manufacturing-zoned TSIIC-secured From 2026
Unit A — Key Figures
Gross area~25,000 sq ft
PlotAcre One
DeliveryS&C or Turnkey
ZoningManufacturing
GMP standardsUS FDA / EU / WHO
AvailabilityFrom 2026
Lease typeLong-term
Land titleTSIIC-secured
The Space — Unit A
Genome Valley Phase III manufacturing facility exterior
Exterior · Genome Valley Phase III Manufacturing Facility
Shell-and-core interior ready for tenant fit-out
Shell-and-Core Interior · Tenant Fit-Out Ready
GMP-ready fitted manufacturing interior Genome Valley Phase III
Turnkey GMP-Ready Interior · Genome Valley Phase III
TSIIC Official Layout Plan Biotech Park Phase III Karkapatla
TSIIC · Official Layout Plan · Biotech Park Phase III · Karkapatla Village · 611.92 Acres · Non-SEZ Manufacturing Zone

Site Plan

Location Within the Site

Unit A occupies the remaining buildable footprint on the existing one-acre plot, adjacent to the sponsor's retained 10,000 sq ft unit. Both plots sit on Genome Valley Phase III — the only manufacturing-designated zone within the cluster.

Indicative Site Plan — Genome Valley Phase III Not to scale · Indicative layout
GENOME VALLEY PHASE III ACCESS ROAD PLOT A — 1 ACRE Sponsor Unit 10,000 sq ft · RETAINED UNIT A ~25,000 sq ft YOU ARE HERE Plot B — 1.3 Acres (see Unit B) N Unit A (this unit) Sponsor (retained) Plot B (separate unit)

Full Specification

Unit A — Technical Overview

Gross Floor Area
~25,000 sq ft
Plot
Acre One, Genome Valley Phase III
Zoning Classification
Manufacturing
Phase III exclusive — only manufacturing-zoned area in Genome Valley
Delivery Options
Shell-and-Core or Turnkey
Fully fitted cleanroom-ready option available
GMP Compliance
US FDA / EU GMP / WHO
Built to tenant's regulatory standard
Cleanroom Capability
Available on turnkey basis
ISO classification to tenant specification
Land Title
TSIIC-secured
Government-backed Telangana Infrastructure Fund
Statutory Approvals
15-day guarantee
Via TS-iPASS Right to Clearance law
Lease Structure
Long-term lease
Terms to be agreed; standard market 10+ year
Availability
From 2026
Existing Neighbour
Sponsor unit (10,000 sq ft)
Pharmaceutical manufacturing, operational from 2026
Policy Incentives
Telangana LS Policy 2023–28
Capital subsidies and tax incentives available

Delivery Options

Shell-and-Core or Turnkey — Your Choice

We accommodate both established domestic companies that prefer to control their own fit-out, and international companies that want a fully ready facility from day one.

Shell-and-Core

You Fit Out to Your Standard

We deliver a fully weathertight building with structural slab, mains services connected (power, water, drainage), and a GMP-ready building fabric. You install your own cleanrooms, HVAC, process equipment, and finishes — fully to your regulatory specification. This is the standard model for established Indian pharma companies and gives you complete control over your manufacturing environment.

Weathertight structure delivered Mains services connected GMP-ready building fabric Tenant controls full fit-out 10+ year lease typical
Turnkey

Arrive Ready to Manufacture

We deliver a fully fitted, cleanroom-ready manufacturing facility to your brief — including HVAC, clean utilities, epoxy flooring, clean wall and ceiling systems, and all regulatory infrastructure. Designed for international companies entering India who want to focus capital on operations rather than construction, and for companies on compressed timelines.

Full cleanroom installation HVAC and clean utilities Regulatory-ready from day one Designed to your brief Faster operational timeline

Interested in Unit A?

Tell us about your manufacturing requirements and we will respond within 48 hours with a detailed proposal.

Submit an Enquiry View Unit B Instead